NSEBSECOMMODITYNASDAQNYSEFOREXINDICESAMEXUSA .

Famous Munafa Ebook, free scanners! Intraday scanner, FNO scanner, High profit BTST stocks!

Summit Therapeutics (SMMT) Technical (Analysis) Reports Summit Therapeutics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com

Complete & easy to understand technical analysis of Summit Therapeutics (SMMT)

Technical Analysis Report for NASDAQ stock SMMT Summit Therapeutics. Dated: 25 Jun 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in NASDAQ stock exchange

If you are looking for Tomorrow's Movement Predictions for NASDAQ stock SMMT Summit Therapeutics then click here. or read Experts views on Summit Therapeutics or Forecast & share price targets of Summit Therapeutics

Summit Therapeutics Opened at 14.22 and Closed at: 14.17, which is -0.56% of previous session's close. It moved within a range of 14.05 and 14.53
The session was a Bearish session with an average volume of 3123869, which is -116.72% of previous session's volumes.

• The stock has fallen, and its short term trend is also negative and in a downtrend.
• The stock has fallen, and its mid term trend is also negative and in a downtrend.
• The stock has fallen, and its long term trend is also negative and in a downtrend.

Support for tomorrow is 13.87 and resistance for tomorrow is 14.35
These support and resistance points are valid for the first 5-15 minutes charts

Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.

Support for tomorrow's hourly charts is 13.97, 13.77 resistance for tomorrow's hourly charts is 14.45, 14.73

10 Day SMA for Summit Therapeutics (SMMT) is 13.99 and stock is trading above these levels. This is a good sign for its short term trend

20 Day SMA for Summit Therapeutics (SMMT) is 14.57 and the stock is trading below these levels. This is not a good sign for its mid term trend

50 Day SMA for Summit Therapeutics (SMMT) is 17.57 and the stock is trading below these levels. This is not a good sign for its mid to long term trend

100 Day SMA is 17.04 and the stock is trading below these levels. This is not a good sign for its long term trend

200 Day SMA Summit Therapeutics is 17.77 and stock is trading below these levels. This is not a good sign for its long term trend

20 DMA of Summit Therapeutics is at 14.57 and 200 DMA is at 17.77, while 50 DMA and 100 DMA are at 17.57 and 17.04 respectively

Summit Therapeutics (SMMT) moving average of 20 SMA is at 14.57 and 20 EMA is at 14.75

Summit Therapeutics (SMMT) moving average of 50 SMA is at 17.57 and 50 EMA is at 16.18

Summit Therapeutics (SMMT) moving average of 100 SMA is at 17.04 and 100 EMA is at 17.05

Summit Therapeutics (SMMT) moving average of 200 SMA is at 17.77 and 200 EMA is at 17.97

Summit Therapeutics has performed better than Spero Therapeutics in short term. Holding Summit Therapeutics could be a better choice for now!

Si Bone has performed better than Summit Therapeutics in short term. You could have earned much better returns by investing in Si Bone, about 34.92% more returns!

Phio Pharmaceuticals has performed better than Summit Therapeutics in short term. You could have earned much better returns by investing in Phio Pharmaceuticals, about 3.7% more returns!

Mimedx Group has performed better than Summit Therapeutics in short term. You could have earned much better returns by investing in Mimedx Group, about 22.42% more returns!

Alnylam Pharmaceuticals has performed better than Summit Therapeutics in short term. You could have earned much better returns by investing in Alnylam Pharmaceuticals, about 14.71% more returns!

Amgen Inc has performed better than Summit Therapeutics in short term. You could have earned much better returns by investing in Amgen Inc, about 23.47% more returns!

Array Biopharma has performed better than Summit Therapeutics in short term. You could have earned much better returns by investing in Array Biopharma, about 1.66% more returns!

Biolinerx has performed better than Summit Therapeutics in short term. You could have earned much better returns by investing in Biolinerx, about 5.52% more returns!

Eton Pharmaceuticals has performed better than Summit Therapeutics in short term. You could have earned much better returns by investing in Eton Pharmaceuticals, about 27.9% more returns!

Gilead Sciences has performed better than Summit Therapeutics in short term. You could have earned much better returns by investing in Gilead Sciences, about 9.52% more returns!

Grifols S has performed better than Summit Therapeutics in short term. You could have earned much better returns by investing in Grifols S, about 10.97% more returns!

Immutep has performed better than Summit Therapeutics in short term. You could have earned much better returns by investing in Immutep, about 11.79% more returns!

Summit Therapeutics Technical analysis of indicators

Price action analysis of Summit Therapeutics (SMMT) based on a short term time period is neutral. A longer time frame might give a better analysis.

ADX buy sell signal for Summit Therapeutics stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.

MACD generated a BUY signal for Summit Therapeutics in short term but the buy signal is initial and weak.

MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.

Summit Therapeutics Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting tired and bears are picking up momentum.

Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down

CCI has generated a SELL signal for Summit Therapeutics in short term but SELL signal is weak.

RSI is generating a SELL signal in short term but selling is losing momentum.

MRSI is in negative zone. This is the SELL zone

Although the stock is in the SELL zone, but selling might be slowing down

Stock of Summit Therapeutics is picking up selling momentum according to indicator.

Volume based indicators are showing selling momentum.

Volume Weighted Averaged Price (VWAP) for short term is 13.99 and Summit Therapeutics SMMT stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.

People seem to be coming out and selling the Summit Therapeutics SMMT stock. Volume based technical analysis of Summit Therapeutics SMMT stock is negative.

Summit Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.

Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.

Tomorrow's Predictions

You should also read Tomorrow's Movement Predictions for NASDAQ stock SMMT Summit Therapeutics These predictions are based on various factors, are easy to understand, and upto 75% accurate!

And SMMT Experts View which covers a lot of information including buying and selling signals

SMMT future forecast & share price targets

You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Summit Therapeutics or View Candle Stick Charts here

Share on: WhatsApp Facebook Tweet